Aortic aneurysms: current pathogenesis and therapeutic targets

Cited 45 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorMin Ji Cho-
dc.contributor.authorM R Lee-
dc.contributor.authorJong Gil Park-
dc.date.accessioned2024-01-08T16:33:03Z-
dc.date.available2024-01-08T16:33:03Z-
dc.date.issued2023-
dc.identifier.issn1226-3613-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/33235-
dc.description.abstractAortic aneurysm is a chronic disease characterized by localized expansion of the aorta, including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic aneurysms are generally asymptomatic, they can threaten human health by sudden death due to aortic rupture. Aortic aneurysms are estimated to lead to 150,000 ~ 200,000 deaths per year worldwide. Currently, there are no effective drugs to prevent the growth or rupture of aortic aneurysms; surgical repair or endovascular repair is the only option for treating this condition. The pathogenic mechanisms and therapeutic targets for aortic aneurysms have been examined over the past decade; however, there are unknown pathogenic mechanisms involved in cellular heterogeneity and plasticity, the complexity of the transforming growth factor-β signaling pathway, inflammation, cell death, intramural neovascularization, and intercellular communication. This review summarizes the latest research findings and current pathogenic mechanisms of aortic aneurysms, which may enhance our understanding of aortic aneurysms.-
dc.publisherSpringer-Nature Pub Group-
dc.titleAortic aneurysms: current pathogenesis and therapeutic targets-
dc.title.alternativeAortic aneurysms: current pathogenesis and therapeutic targets-
dc.typeArticle-
dc.citation.titleExperimental and Molecular Medicine-
dc.citation.number12-
dc.citation.endPage2530-
dc.citation.startPage2519-
dc.citation.volume55-
dc.contributor.affiliatedAuthorMin Ji Cho-
dc.contributor.affiliatedAuthorJong Gil Park-
dc.contributor.alternativeName조민지-
dc.contributor.alternativeName이미란-
dc.contributor.alternativeName박종길-
dc.identifier.bibliographicCitationExperimental and Molecular Medicine, vol. 55, no. 12, pp. 2519-2530-
dc.identifier.doi10.1038/s12276-023-01130-w-
dc.description.journalClassY-
Appears in Collections:
Division of Research on National Challenges > Stem Cell Convergenece Research Center > 1. Journal Articles
Division of A.I. & Biomedical Research > Biotherapeutics Translational Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.